• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CRF Health launches TrialConsent 2.0 Platform

CRF Health launches TrialConsent 2.0 Platform

June 19, 2017
CenterWatch Staff

CRF Health, a global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches version 2 of TrialConsent, offering new enhancements to the industry’s first electronic informed consent solution with a fully embedded design tool.

The solution promotes better comprehension, compliance and retention rates while reducing regulatory risk. TrialConsent 2.0 marks a significant advance in electronic informed consent by offering an improved user interface with enhanced navigation for participants and site personnel. Sponsors, Institutional Review Boards, Ethics Committees and research sites also benefit from the improved collaboration offered by the solution and much simplified review process.    

Rachael Wyllie, CEO commented, “CRF Health is committed to simplifying the path to approval, streamlining complex processes and delivering reliable results for superior clinical trial outcomes. The forward-thinking architecture behind TrialConsent 2.0 allows the platform to be fully integrated with an existing eCOA solution or delivered as a stand-alone solution, simplifying and providing consistency, control and flexibility to the informed consent process. Comprehensive reporting enables study teams and ethics committees to monitor the consent status of sites and participants, track and analyze compliance and ultimately make smarter decisions. We firmly believe this advancement represents a step change in the way Informed Consent can be managed throughout its lifecycle.”

Upcoming Events

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Qualification-360x240.png

    Sites and Sponsors Streamlining Qualification Efforts with Technology, Process Revisions

  • New Algorithm Tested and Validated by CSDD Highly Predictive of Patient Burden

  • MachineLearning-360x240.png

    Industry Using AI/ML to Improve Data, Quality and Trial Management, Survey Says

  • VirtualTraining-360x240.png

    Virtual Training Evolves into More In-Depth Learning, Improved Communications

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing